AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013. At AbbVie, we believe the world needs new approaches to addressing today’s health issues – from life-threatening illness to chronic conditions. We are transforming the power of our past into new opportunities to advance science and improve lives. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie aims to help patients live healthier lives and collaborate on sustainable healthcare solutions. Through our science, our expertise, and our collaboration, we continue to advance our purpose of having greater impact on the lives of millions of people around the world. AbbVie employ approximately 28,000 people worldwide and markets medicines in more than 170 countries.